The American Society of Radiation Oncology (ASTRO) has raised concerns about proposed additional payment cuts to radiation therapy in the proposed Medicare Physician Fee Schedule (MPFS) for 2016, released July 8, 2015. All changes would take effect on Jan. 1, 2016.
As today’s healthcare industry continues to shift toward a value-based model, radiology practices are facing increased ...
Leading radiosurgery experts presented their experiences with Automatic Brain Metastases Planning software at the Novalis Circle Symposium during this year’s American Association of Physicists in Medicine (AAPM) annual meeting and exhibition. The software consistently and rapidly generates radiosurgery plans, allowing clinicians to efficiently treat up to 10 multiple brain metastases in one session while helping minimize radiation exposure to healthy surrounding tissue.
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
Shimadzu Medical Systems USA announced the availability of T-smart, a new tomographic image reconstruction function using iterative reconstruction. The algorithm improves the clarity of tomosynthesis-acquired orthopedic images containing metal implanted objects such as used in orthopedics. T-smart made its U.S. debut at the 2015 Association for Medical Imaging Management (AHRA) annual meeting of radiology hospital administrators, held July 19-22 in Las Vegas.
Dramatic increases in pediatric emergency department visits for sports-related head injuries over the past decade are leading to high numbers of unnecessary computed tomography (CT) scans, according to new research. The aggregate result of this increase is higher radiation exposure and higher cost of treatment.
Researchers at the University of Kentucky’s Sanders-Brown Center on Aging are on the hunt for biomarkers that might serve as an early warning system for Alzheimer’s disease (AD).
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
July 31, 2015 — The American Society of Echocardiography (ASE) released a new document describing various imaging ...
Joseph Deasy, Ph.D., discusses his study on dose-volume relations for late rectal bleeding in 1,001 patients from five ...
After a tornado decimated the hospital only four years ago, Mercy Hospital Joplin in Joplin, Missouri, reopened its doors in March with a new, 900,000-square-foot facility with state-of-the-art equipment. Part of the acquisition by Mercy Hospital Joplin, formerly St. John’s Regional Medical Center, included eight Aplio 300 Platinum ultrasound systems from Toshiba America Medical Systems Inc.
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc99m-tilmanocept, a Manocept platform product, to localize in high-risk atherosclerotic plaques. The study — funded through a $321,000 Phase 1 Small Business Innovation Research (SBIR) grant from the National Heart, Lung and Blood Institute (NHLBI), National Institute of Health (NIH) — will be conducted with Massachusetts General Hospital (MGH) and Harvard Medical School.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Breast biopsy systems are used to take tissue samples of suspected cancer inside the breast for pathology testing.
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed two near-infrared (NIR) contrast agents that are efficiently taken up by the thyroid and parathyroid glands following intravenous injection. The researchers tested the contrast agents in rats and pigs and showed that they could be used to help distinguish the thyroid and parathyroid glands from surrounding tissue and from each other. Their findings appeared in the Jan. 5, 2015, issue of Nature Medicine.
Teams at the Willis-Knighton Cancer Center in Shreveport, Louisiana, have achieved high levels of quality care, ease of use and speed of treatment in 11 months on IBA’s Proteus One compact proton therapy system.
August 04, 2015 